Business Description
Adlai Nortye Ltd. is a Cayman Islands-based company founded in 2004 that focuses on developing new cancer treatments across the United States and other markets. The company has several drugs in early-stage clinical trials, targeting a range of cancers including pancreatic, lung, colorectal, esophageal, and rectal cancer. Its pipeline includes treatments that work by helping the immune system recognize and attack tumors, as well as drugs that block specific proteins known to drive cancer growth.
